Free Trial
ASX:CT1

Constellation Technologies (CT1) Stock Price, News & Analysis

Constellation Technologies logo

About Constellation Technologies Stock (ASX:CT1)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
983,646 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Constellation Technologies Limited engages in the development and management of Internet of Things (IoT) products for industry and government applications in Australia, the United States, China, and the Middle East. The company provides solutions to cloud, IoT, edge-computing sensors, big data, analytics, machine learning, artificial intelligence, and other advanced technologies. It also offers IoT systems and development, digital twin solutions, IoT hardware development, and digital engineering services. The company was incorporated in 1987 and is based in Melbourne, Australia.

Receive CT1 Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Constellation Technologies and its competitors with MarketBeat's FREE daily newsletter.

CT1 Stock News Headlines

2024's Must-Watch Stocks!
Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.
See More Headlines

CT1 Stock Analysis - Frequently Asked Questions

Constellation Technologies Limited (ASX:CT1) posted its quarterly earnings data on Thursday, February, 28th. The company reported $0.00 earnings per share (EPS) for the quarter. Constellation Technologies had a negative trailing twelve-month return on equity of 13.27% and a negative net margin of 9.04%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Constellation Technologies investors own include Neuren Pharmaceuticals (NEU), Macquarie Group (MQG), Magellan Financial Group (MFG), Medlab Clinical (MDC), FBR (FBR), Embark Early Education (EVO) and Dreadnought Resources (DRE).

Company Calendar

Last Earnings
2/28/2019
Today
11/18/2024

Industry, Sector and Symbol

Industry
Information Technology Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.35 million

Miscellaneous

Outstanding Shares
1,470,000,000
Free Float
N/A
Optionable
Not Optionable
Beta
1.40
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (ASX:CT1) was last updated on 11/18/2024 by MarketBeat.com Staff
From Our Partners